phase readout
saveNCT06492226: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®
COMPLETEDupdated 22h ago
community read0 votes
Sponsor: Xentria, Inc.. Phase: PHASE1. Conditions: Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that